经皮喉部超声评估注射喉成形术中透明质酸状态
该研究纳入17例男性与38例女性接受透明质酸注射喉成形术的患者,采用经皮喉部超声监测透明质酸吸收与迁移。多因素Cox回归显示注射原因是透明质酸吸收最重要的独立预测因素(HR 2.15,95%CI 1.03-4.46,p=0.040)。单侧声带麻痹患者透明质酸维持时间显著长于声带萎缩患者(8.77 vs. 4.70个月,HR 2.33,95%CI 5.47-8.18,p=0.002)。
要点
- 经皮喉部超声可客观评估透明质酸注射喉成形术后透明质酸的状态。
- 注射原因是透明质酸吸收的独立预测因素(HR 2.15,95%CI 1.03-4.46,p=0.040)。
- 单侧声带麻痹患者透明质酸维持时间长于声带萎缩患者(8.77 vs. 4.70个月,p=0.002)。
核心结论
- 经皮喉部超声是评估透明质酸注射喉成形术后患者的客观方法,可基于随访中的超声发现提供个体化管理。
- 对于上呼吸道感染高风险或无法耐受软性鼻咽镜的患者,经皮喉部超声可作为评估透明质酸注射喉成形术后声门状况的替代工具。
研究设计与样本
- 研究纳入诊断为单侧声带麻痹或声带萎缩的患者,所有患者均在诊室接受透明质酸注射喉成形术,并用经皮喉部超声监测透明质酸状态。
- 经皮喉部超声评估计划包括注射前及注射后多次评估,直至透明质酸不可见。
- 研究人群包括38例女性和17例男性;54.1%的患者因单侧声带麻痹接受注射喉成形术,45.9%因声带萎缩接受注射喉成形术。
- 证据等级为4级。
主要发现
- 多因素Cox回归分析显示,注射原因是影响透明质酸吸收的最重要独立预测因素(HR 2.15,95%CI 1.03-4.46,p=0.040)。
- 单侧声带麻痹患者透明质酸维持时间显著长于声带萎缩患者(8.77 vs. 4.70个月,HR 2.33,95%CI 5.47-8.18,p=0.002)。
临床怎么用
- 作者认为,经皮喉部超声是评估透明质酸注射喉成形术后患者的客观方法,随访中可基于超声发现提供个体化管理。
- 作者认为,对于上呼吸道感染高风险或无法耐受软性鼻咽镜的患者,经皮喉部超声可作为评估透明质酸注射喉成形术后声门状况的替代工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Injection laryngoplasty (IL) with hyaluronic acid (HA) is an effective treatment for patients with glottic insufficiency. The duration of HA maintenance in the vocal fold remains unknown. In this study, transcutaneous laryngeal ultrasound (TLUS) was used to evaluate the absorption and migration of HA after IL. Subsequent management might be provided based on the TLUS finding. METHODS: Patients diagnosed with unilateral vocal fold paralysis (UVFP) or vocal fold atrophy were recruited. All patients underwent IL with HA in an office-based setting along with TLUS to monitor the status of HA. The schedule of TLUS included assessments before and after IL until non-visualization. RESULTS: The study population comprised 38 women and 17 men. Of the patients, 54.1% underwent IL for UVFP, whereas 45.9% underwent IL for vocal fold atrophy. Multivariate Cox regression analysis for factors affecting HA absorption revealed that the cause of injection was the most important independent predictor (hazard ratio [HR], 2.15; 95% confidence interval [CI], 1.03-4.46; p = 0.040). The duration of HA maintenance was significantly longer in patients with UVFP than in those with vocal fold atrophy (8.77 vs. 4.70 months, HR, 2.33; 95% CI, 5.47-8.18; p = 0.002). CONCLUSION: TLUS is an objective assessment method for patients undergoing IL with HA. Subsequent tailor-made management could be offered based on the TLUS findings during follow-up. For patients at high risk of upper respiratory tract infection or who are intolerant to flexible nasopharyngoscopy, TLUS can be used as an alternative tool to evaluate the condition of the glottis after IL with HA. LEVEL OF EVIDENCE: 4 Laryngoscope, 134:4682-4687, 2024.
引用
- Chang CF, Kuo YL, Hsu YB, et al. Transcutaneous Laryngeal Ultrasound for Assessing Hyaluronic Acid Status in Patients Undergoing Injection Laryngoplasty. Laryngoscope. 2024. PMID: 38953589. doi:10.1002/lary.31614
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。